The effect of mirtazapine in panic disorder: An open label pilot study with a single-blind placebo run-in period

International Clinical Psychopharmacology

Volumn 16, Issue 6, 2001, Pages 363-368

  Boshuisen, M L ^a   Slaap, B R ^a   Vester Blokland, E D ^b   Den Boer, J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

Mirtazapine; Panic disorder; Therapy

Indexed keywords

MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGORAPHOBIA; APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0034764918     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200111000-00008     Document Type: Article

References (24)

1. Guidelines on psychotropic drugs for the EC - Clinical investigation of medicinal products in the treatment of generalized anxiety disorder, panic disorder and obsessive-compulsive disorder
2. Mirtazapine in the treatment of panic disorder
3. Clinical experience with mirtazapine in the treatment of panic disorder
4. Antidepressant-induced sexual dysfunction
5. A pilot study of mirtazapine in post-traumatic stress disorder
6. The alpha2-antagonist Org 3770 enhances serotonin transmission in vivo
7. 1a mediated serotonergic neurotransmjssion
8. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline
9. Involvement of serotonin receptor subtypes in panic disorder: A critical appraisal of the evidence
10. SCL-90: An outpatient psychiatric rating scale: Preliminary report
11. A meta-analysis of eight randomized, double blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety
12. Mirtazapine in major depression with comorbid generalized anxiety disorder
13. Mirtazapine: Clinical overview
14. The assessment of anxiety states by rating
15. Development of a rating scale for primary depressive illness
16. Panic disorder: Pathophysiology and drug treatment
17. Brief standard self-rating for phobic patients
18. Safety of mirtazapine: A review
19. Care of depressed patients with anxiety symptoms
20. Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers
21. The role of SSRIs in panic disorder
22. Mirtazapine versus selective serotonin reuptake inhibitors
23. The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action